|
Preliminary findings from a consensus building process to update financial advocacy services guidelines. |
|
|
Employment - AstraZeneca (I); Bristol-Myers Squibb (I); Genentech (I); Repligen (I); Teladoc (I) |
Stock and Other Ownership Interests - Roche (I) |
Consulting or Advisory Role - Genentech |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Daiichi Sankyo; Pfizer |
Speakers' Bureau - Coherus BioSciences |
Travel, Accommodations, Expenses - Coherus BioSciences |
|
|
Employment - Green Bay Oncology |
Honoraria - Daiichi Sankyo |
Consulting or Advisory Role - Pfizer |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |